Shanmuga Hospital Ltd
₹ 45.5
6.73%
16 Oct
- close price
About
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital situated in Salem, Tamil Nadu.[1]
Key Points
- Market Cap ₹ 61.9 Cr.
- Current Price ₹ 45.5
- High / Low ₹ 56.8 / 34.0
- Stock P/E 14.6
- Book Value ₹ 31.2
- Dividend Yield 0.00 %
- ROCE 12.6 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 16.3%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 38.94 | 37.11 | 40.63 | 45.41 | 44.97 | |
| 29.90 | 29.82 | 32.03 | 37.16 | 36.69 | |
| Operating Profit | 9.04 | 7.29 | 8.60 | 8.25 | 8.28 |
| OPM % | 23.22% | 19.64% | 21.17% | 18.17% | 18.41% |
| 0.09 | 0.15 | 0.34 | 0.23 | 0.63 | |
| Interest | 0.03 | 0.28 | 0.61 | 0.63 | 0.42 |
| Depreciation | 0.13 | 0.58 | 1.30 | 2.16 | 2.82 |
| Profit before tax | 8.97 | 6.58 | 7.03 | 5.69 | 5.67 |
| Tax % | 24.97% | 27.66% | 25.18% | 26.01% | 25.75% |
| 6.72 | 4.76 | 5.25 | 4.21 | 4.21 | |
| EPS in Rs | 6.86 | 4.86 | 5.36 | 3.09 | 3.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -4% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 16% |
| Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.08 | 0.08 | 9.80 | 13.61 | 13.61 |
| Reserves | 6.98 | 11.74 | 7.34 | 26.09 | 28.89 |
| 0.00 | 7.65 | 9.02 | 7.61 | 6.73 | |
| 3.59 | 3.58 | 7.76 | 5.47 | 3.82 | |
| Total Liabilities | 10.65 | 23.05 | 33.92 | 52.78 | 53.05 |
| 2.28 | 9.97 | 15.85 | 22.43 | 37.64 | |
| CWIP | 0.00 | 0.00 | 4.34 | 0.00 | 2.44 |
| Investments | 0.00 | 0.02 | 0.02 | 0.03 | 0.03 |
| 8.37 | 13.06 | 13.71 | 30.32 | 12.94 | |
| Total Assets | 10.65 | 23.05 | 33.92 | 52.78 | 53.05 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 1.92 | 2.95 | 9.58 | -12.64 | 12.31 | |
| -1.67 | -8.31 | -11.59 | -4.48 | -20.33 | |
| -0.03 | 7.37 | 0.90 | 16.39 | -2.65 | |
| Net Cash Flow | 0.21 | 2.00 | -1.12 | -0.73 | -10.66 |
| Free Cash Flow | 0.24 | -5.32 | -1.93 | -17.04 | -8.16 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 22% | 71% | 129% | -117% | 159% |
Ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 44.15 | 57.64 | 62.53 | 63.98 | 55.68 |
| Inventory Days | 19.06 | 36.41 | |||
| Days Payable | 17.99 | 34.33 | |||
| Cash Conversion Cycle | 45.22 | 59.71 | 62.53 | 63.98 | 55.68 |
| Working Capital Days | 33.93 | 27.05 | -12.85 | 67.92 | 40.18 |
| ROCE % | 51.72% | 33.53% | 17.20% | 12.62% |
Insights
In beta| Mar 2025 | Mar 2026 | |
|---|---|---|
| Average Bed Occupancy Rate % |
|
|
| Average Length of Stay (ALOS) days |
||
| Average Revenue Per Bed (ARPB) INR |
||
| Inpatient Volume patients |
||
| Operational Beds beds |
||
| Outpatient Volume visits |
||
| Total Bed Capacity beds |
||
| Robotic Surgeries Performed surgeries |
||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period from 01.07.2026 to 30.09.2026
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after Q2 FY2026 results.
-
Increase In Authorised Share Capital Of The Company
- Members approved authorized share capital increase from Rs.14 crore to Rs.25 crore at 18 September 2026 AGM.
-
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- Shareholders approved MOA/AOA changes at 6th AGM, adding healthcare services and software businesses, subject to ROC approval.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved CS S Anuradha as Secretarial Auditor for FY2026-27 to FY2030-31.
Business Overview:[1][2]
SHL is in the service of providing multi-
specialty healthcare solutions, medical expertise, advanced technology, and patient-centric care through a hospital located in Salem in Tamil Nadu. Co. is engaged in establishing, maintaining, and promoting healthcare institutions in India for medical relief.
Its activities cover hospitals, nursing homes, multi speciality wards, rehabilitation centers,
ICUs, ICCUs, diagnostic and scan centers,
health centers, physiotherapy units, labs, dispensaries, blood banks, and crèches.
By supporting a wide range of facilities and services, the Company ensures comprehensive healthcare delivery, spanning treatment, diagnostics, rehabilitation, and preventive care.